South African drug maker Aspen Pharmacare will invest an additional R3.4 billion ($231 million) at its Port Elizabeth plant, it said on Friday at an investment summit in Johannesburg. The investment will be used to manufacture sterile anaesthetics, Aspenâ€™s senior executive Stavros Nicolaou said at the summit.